Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
11 papers
Recent·Most cited
A. Tarke, Y. Zhang, N. Methot, T. N. Narowski, E. Phillips, S. Mallal, A. Frazier, G. Filaci, D. Weiskopf, J. M. Dan, P. Lakshmanane, R. H. Scheuermann, A. Sette, A. Grifoni
This study identifies T cell epitopes and cross-reactivity patterns across common cold coronaviruses, highlighting conservation and limitations in cross-reactivity among subgenera.
bioRxiv · Jan 4, 2023Immunology
A. Grifoni, Y. Zhang, A. Tarke, J. Sidney, P. Rubiro, M. Reina-Campos, G. Filaci, J. M. Dan, R. H. Scheuermann, A. Sette
The paper predicts MPXV T cell epitopes using VACV epitope data and identifies immunodominant targets to design peptide pools for detecting cross-reactive T cells in vaccinated individuals.
bioRxiv · Sep 6, 2022 · PreprintImmunology
Z. Zhang, J. Mateus, C. H. Coelho, J. M. Dan, C. R. Moderbacher, R. I. Galvez, F. H. Cortes, A. Grifoni, A. Tarke, J. Chang, E. A. Escarrega, C. Kim, B. Goodwin, N. I. Bloom, A. Frazier, , S. Crotty
This study evaluates immune memory responses to four COVID-19 vaccines over six months, finding stable T and B cell memory but declining neutralizing antibodies with mRNA vaccines.
bioRxiv · Mar 18, 2022Immunology
J. E. Bowen, K. R. Sprouse, A. C. Walls, I. G. Mazzitelli, J. K. Logue, N. M. Franko, K. Ahmed, A. Shariq, E. Cameroni, A. Gori, A. Bori, C. M. Posavad, J. M. Dan, Z. Zhang, D. Weiskopf, , D. Veesler
This study evaluates neutralizing activity against Omicron BA.1 and BA.2 variants elicited by various vaccines and finds that booster doses enhance neutralizing titers and breadth across all vaccine platforms.
bioRxiv · Mar 15, 2022 · PreprintImmunology
A. Tarke, C. H. Coelho, Z. Zhang, J. M. Dan, E. D. Yu, N. Methot, N. I. Bloom, B. Goodwin, E. Phillips, S. Mallal, J. Sidney, G. Filaci, D. Weiskopf, R. da Silva Antunes, S. Crotty, , A. Sette
This study shows that SARS-CoV-2 vaccines induce T cell responses that cross-recognize variants from Alpha to Omicron, with high preservation of CD4+ and CD8+ T cell epitopes.
bioRxiv · Dec 28, 2021 · PreprintImmunology
E. D. Yu, E. Wang, E. Garrigan, B. Goodwin, A. Sutherland, J. Chang, R. I. Galvez, J. Mateus, S. A. Rawlings, D. M. Smith, A. Frazier, D. Weiskopf, J. M. Dan, S. Crotty, A. Grifoni, , R. da Silva Antunes
This study develops a T cell-based method to distinguish between SARS-CoV-2 infection and vaccination by analyzing T cell reactivity to specific epitopes, achieving high classification accuracy across different groups.
bioRxiv · Dec 15, 2021 · PreprintImmunology
S. Sinha, V. Castillo, C. R. Espinoza, C. Tindle, A. G. Fonseca, J. M. Dan, G. D. Katkar, S. Das, D. Sahoo, P. Ghosh
This study identifies shared cellular and molecular features between severe COVID-19 and idiopathic pulmonary fibrosis, highlighting ER stress and AT2 cell dysfunction as key drivers.
bioRxiv · Nov 28, 2021Immunology
A. Tarke, J. Sidney, N. Methot, Y. Zhang, J. M. Dan, B. Goodwin, P. Rubiro, A. Sutherland, R. da Silva Antunes, A. Fraizer, S. A. Rawlings, D. M. Smith, B. Peters, R. H. Scheuermann, D. Weiskopf, , A. Sette
The paper analyzes T cell responses to SARS-CoV-2 variants and finds minimal impact on CD4+ and CD8+ T cell reactivity in convalescents and vaccinees.
bioRxiv · Feb 27, 2021Immunology
A. Tarke, J. Sidney, C. K. Kidd, J. M. Dan, S. I. Ramirez, E. D. Yu, J. Mateus, R. da Silva Antunes, E. Moore, P. Rubiro, N. Methot, E. J. Phillips, S. Mallal, A. Frazier, S. Rawlings, , A. Sette
The paper identifies SARS-CoV-2 epitopes recognized by CD4+ and CD8+ T cells in COVID-19 patients and develops epitope megapools for their detection.
bioRxiv · Dec 8, 2020Immunology
J. M. Dan, J. Mateus, Y. Kato, K. M. Hastie, E. D. Yu, C. Faliti, A. Grifoni, S. I. Ramirez, S. Haupt, A. Frazier, C. Nakao, V. Rayaprolu, S. A. Rawlings, B. Peters, F. Krammer, , S. Crotty
The paper assesses SARS-CoV-2 immune memory components over eight months post-infection, finding varying kinetics in antibodies, B cells, and T cells.
bioRxiv · Nov 15, 2020 · PreprintImmunology
J. M. Dan, C. Havenar-Daughton, K. Kendric, K. Kaushik, S. Rosales, E. Anderson, C. LaRock, P. Vijayanand, G. Seumois, D. Layfield, R. Cutress, C. Ottensmeier, C. Lindestam Arlehamn, A. Sette, V. Nizet, , S. Crotty
The paper investigates recurrent Group A Streptococcus tonsillitis and finds it involves antibody deficiency and aberrant Tfh cells, with genetic factors contributing to susceptibility.
bioRxiv · Jun 27, 2018Immunology